Germany_Dr. Inge Herrmann of EMPA from St. Gallen presents a new therapy against sepsis© BioLAGO

Morethan 80 experts came together to discuss innovations in drug development and medicine. The University of Konstanz and the BioLAGO partner network “NanobioNet” were co-organisers of the event. Sepsis is still one of the most dangerous diseases leading to death in a short period of time. Only rapid diagnosis and improvements in therapy can help to reduce today’s mortality rate of 60 %. Inge Herrman of the Research Institute Empa (St. Gallen, Switzerland) presented the development of a new therapy that uses nanoparticles to filter foreign particles from blood to prevent inflammation. Additionally, attendees from science and industry had the opportunity to use the information booths of biotechnology companies and research institutes to exchange news about latest developments.